Mpox Vaccine Manufacturer Is Profiting From Accelerating Global Health Emergency

A U.S.-based watchdog group on Friday called out what it described as the “profiteering approach” taken by one of the only companies in the world with an approved vaccine for mpox, an infectious disease whose rapid spread in the Democratic Republic of Congo prompted the World Health Organization to declare a global emergency earlier this month. Peter Maybarduk, the director of Public Citizen’…

Source